Clinical Trials Directory

Trials / Completed

CompletedNCT01630161

Smoking Relapse-Prevention Intervention for Cancer Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
441 (actual)
Sponsor
H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to test different ways to help cancer patients maintain their smoking abstinence. Participants may receive educational materials as part of the study.

Detailed description

This study involves participation at four distinct time points over a one-year period. * Baseline assessment * 2-month follow-up telephone call * 6-month follow-up telephone call * 12-month follow-up telephone call

Conditions

Interventions

TypeNameDescription
BEHAVIORALUsual CareStandard care includes routine assessment of smoking behavior and brief clinical intervention. Smoking counseling for all participants in the current study will be completed by a Certified Tobacco Treatment Specialist consisting consists of brief counseling (\<15 minutes) based on the 5 A's Clinical Practice Guidelines; Ask about tobacco use, Advise to quit, Assess willingness to make a quit attempt, Assist in quit attempt, Arrange for follow-up (Fiore et al., 2008). Patients receive information for local and state smoking resources (e.g., Quitline), pharmacotherapy options, and if interested, assistance with obtaining a prescription for pharmacotherapy. Follow-up with patients occurs at 2-weeks, only among those who are prescribed smoking medications (i.e., Varenicline, Bupropion).
BEHAVIORALSmoking Relapse Prevention for Cancer Patients (SRP-CaP)The proposed multimodal intervention consists of a series of easy-to-read relapse prevention booklets (Forever Free) that have shown to be efficacious with a general smoking population (Brandon et al., 2000; 2004), and digital video disk (DVD) customized to the needs of cancer patients (to be developed in Year One).

Timeline

Start date
2012-01-04
Primary completion
2015-05-15
Completion
2020-11-18
First posted
2012-06-28
Last updated
2021-08-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01630161. Inclusion in this directory is not an endorsement.